1 / 7

Rheumatoid Arthritis Drugs Market

Global rheumatoid arthritis drugs market is expected to expand at a CAGR of 2.96% from 2018 to 2026. In 2016, the global market was valued at US$ 19597.43 Mn.

MarketTrends
Download Presentation

Rheumatoid Arthritis Drugs Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Rheumatoid Arthritis Drugs Market Rheumatoid Arthritis Drugs Market Segmentation By Drug Type - Disease-modifying Anti-rheumatic Drugs (DMARDs), Non-steroidal Anti-inflammatory Drugs (NSAIDs), Corticosteroids, Biologic Response Modifiers (Biologics); Distribution Channel, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy Forecast 2018 - 2026 ©2019 Transparency Market Research, All Rights Reserved

  2. Table of Content Sr. No. Content Chapter1 Preface Chapter 2 Assumptions and Research Methodology Chapter 3 Executive Summary Chapter 4 Market Overview Chapter 5 Market Outlook Chapter 6 Global Rheumatoid Arthritis Drugs Market Analysis, by Drug Type Chapter 7 Global Rheumatoid Arthritis Drugs Market Analysis, by Distribution Channel Chapter 8 Global Rheumatoid Arthritis Drugs Market Analysis, by Region Chapter 9 North America Rheumatoid Arthritis Drugs Market Analysis Chapter 10 Europe Rheumatoid Arthritis Drugs Market Analysis Chapter 11 Asia Pacific Rheumatoid Arthritis Drugs Market Analysis Chapter 12 Latin America Rheumatoid Arthritis Drugs Market Analysis Chapter 13 Middle East & Africa Rheumatoid Arthritis Drugs Market Analysis Chapter 14 Competitive Landscape ©2019 Transparency Market Research, All Rights Reserved

  3. Rheumatoid Arthritis Drugs Market - Snapshot Rheumatoid arthritis is an autoimmune disorder that causes pain and inflammation in the joints. Rheumatoid arthritis disease mostly affects the joints of the hand, wrists, elbows, knees, and ankles. Rheumatoid arthritis is also called a musculoskeletal disease, since it causes severe pain and deformity in one or more areas of the musculoskeletal system. ©2019 Transparency Market Research, All Rights Reserved

  4. Reports Highlights •The Rheumatoid Arthritis Drugs Market is anticipated to expand at a stable CAGR of more than 2.5% between 2018 and 2026. •Expansion of the global rheumatoid arthritis drugs market is due to strong R&D and increasing awareness regarding usage of biologic drugs for rheumatoid arthritis treatment during the forecast period. •Demand for development of newer and biotechnologically enhanced products such as biologics and biosimilar is rising globally, owing to the treatment efficiency of drugs. Request For Sample ©2019 Transparency Market Research, All Rights Reserved

  5. Continue.. Rise in investment in R&D programs by key players of the market is likely to boost the market significantly during the forecast period. Major companies focus on strategic alliances for sales and distribution in order to increase business in untapped markets. AbbVie, Inc., Janssen Biotech, Inc., Amgen, Inc., were market leaders in the rheumatoid arthritis drugs market in 2017 Request For Brochure ©2019 Transparency Market Research, All Rights Reserved

  6. Contact To know more about us, please visit our website: www.transparencymarketresearch.com For sales queries or new topics email us on: sales@transparencymarketresearch.com Thank You ©2019 Transparency Market Research, All Rights Reserved

More Related